Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (921-930 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|February 3, 2011
Biosimilar, biobetter and next generation therapeutic antibodiesAlain Beck
Mabs|April 20, 2010
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regionsFiona A Harding, Marcia M Stickler, Jennifer Razo, et al.
Mabs|April 20, 2010
Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunizationRaquel Martín-Folgar, Gema Lorenzo, Hani Boshra, et al.
Mabs|April 21, 2010
Stability of IgG isotypes in serumIvan R Correia
Mabs|July 31, 2010
Assessing monoclonal antibody product quality attribute criticality through clinical studiesAndrew M Goetze, Matthew R Schenauer, Gregory C Flynn
Mabs|August 19, 2010
Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, DenmarkKate Hamer
Mabs|August 19, 2010
Development of a novel mammalian cell surface antibody display platformChen Zhou, Frederick W Jacobsen, Ling Cai, et al.
Mabs|August 3, 2010
The future of monoclonal antibody technologyAlexander Zider, Donald L Drakeman
Mabs|June 4, 2010
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor αDavid J Shealy, Ann Cai, Kim Staquet, et al.
Mabs|June 22, 2010
A comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineeringPhilippe Thullier, Siham Chahboun, Thibaut Pelat
Pageof 184

Showing results (921-930 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|February 3, 2011
Biosimilar, biobetter and next generation therapeutic antibodiesAlain Beck
Mabs|April 20, 2010
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regionsFiona A Harding, Marcia M Stickler, Jennifer Razo, et al.
Mabs|April 20, 2010
Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunizationRaquel Martín-Folgar, Gema Lorenzo, Hani Boshra, et al.
Mabs|April 21, 2010
Stability of IgG isotypes in serumIvan R Correia
Mabs|July 31, 2010
Assessing monoclonal antibody product quality attribute criticality through clinical studiesAndrew M Goetze, Matthew R Schenauer, Gregory C Flynn
Mabs|August 19, 2010
Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, DenmarkKate Hamer
Mabs|August 19, 2010
Development of a novel mammalian cell surface antibody display platformChen Zhou, Frederick W Jacobsen, Ling Cai, et al.
Mabs|August 3, 2010
The future of monoclonal antibody technologyAlexander Zider, Donald L Drakeman
Mabs|June 4, 2010
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor αDavid J Shealy, Ann Cai, Kim Staquet, et al.
Mabs|June 22, 2010
A comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineeringPhilippe Thullier, Siham Chahboun, Thibaut Pelat
Pageof 184